BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2738623)

  • 1. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
    Moertel CG; Rubin J; Kvols LK
    J Clin Oncol; 1989 Jul; 7(7):865-8. PubMed ID: 2738623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
    Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
    Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
    Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
    Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic carcinoid tumour with recombinant interferon alfa.
    Joensuu H; Kumpulainen E; Gröhn P
    Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha.
    Doberauer C; Mengelkoch B; Kloke O; Wandl U; Niederle N
    Acta Oncol; 1991; 30(5):603-5. PubMed ID: 1892678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
    Oberg K; Funa K; Alm G
    N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
    Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
    Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
    Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
    J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
    Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R
    Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of carcinoid syndrome with recombinant interferon alpha-2a.
    Di Bartolomeo M; Bajetta E; Zilembo N; de Braud F; Di Leo A; Verusio C; D'Aprile M; Scanni A; Barduagni M; Barduagni A [corrected to Barduagni M]
    Acta Oncol; 1993; 32(2):235-8. PubMed ID: 7686766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
    Kvols LK
    Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; Hanley JA
    Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
    Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ
    Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
    Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
    Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
    Linkesch M; Kuzmits R; Geyer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
    Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
    Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
    Odurny A; Birch SJ
    Clin Radiol; 1985 Nov; 36(6):597-602. PubMed ID: 2415290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
    Jermendy G; Kónya A; Kárpáti P
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
    Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
    Acta Oncol; 1989; 28(3):439-43. PubMed ID: 2742781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.